Literature DB >> 19894330

Combination of alfacalcidol with calcium can improve quadriceps muscle strength in elderly ambulatory Thai women who have hypovitaminosis D: a randomized controlled trial.

Thawee Songpatanasilp1, La-Or Chailurkit, Akekachai Nichachotsalid, Manoj Chantarasorn.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the efficacy of alfacalcidol and calcium on the improvement of muscle strength in ambulatory elderly Thai women in age group of 65 or more who have hypovitaminosis D. MATERIAL AND
METHOD: Seventy-two postmenopausal women age 65 years or more were enrolled to this study. Blood was collected from all participants for measured of 25(OH)D3, intact PTH and vitamin D receptor (VDR) genotypes. After blood collection, the quadriceps muscle strength was measured using the isokinetic dynamometer device. There were 42 subjects who satisfy the eligible criteria and agreed to participate in the experimental randomized controlled study. These subjects were randomized into two groups, one received calcium 1500 g/day combined with alfacalcidol 0.5 mg/day. Another group received calcium 1500 g/day with placebo.
RESULTS: After 12 weeks of intervention, 40 subjects had the second muscle strength measurement (2 dropped out). By ANCOVA analysis, there were significant improvement of muscle strength in the group that received alfacalcidol compared to placebo in both 30 degrees/sec (20.28 vs.16.29, p = 0.025) and 60 degrees/sec (20.32 vs. 15.05, p = 0.002) angular velocities.
CONCLUSION: Daily doses of 0.5 mg alfacalcidol with calcium effectively improved muscle strength in elderly Thai women who had low level of 25(OH)D3 compared to calcium alone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19894330

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  7 in total

1.  Low-dose vitamin D supplementation and incident frailty in older people: An eight year longitudinal study.

Authors:  Francesco Bolzetta; Brendon Stubbs; Marianna Noale; Alberto Vaona; Jacopo Demurtas; Stefano Celotto; Alberto Cester; Stefania Maggi; Ai Koyanagi; Emanuele Cereda; Nicola Veronese
Journal:  Exp Gerontol       Date:  2017-11-11       Impact factor: 4.032

2.  Is vitamin D a determinant of muscle mass and strength?

Authors:  Isabel Marantes; Sara J Achenbach; Elizabeth J Atkinson; Sundeep Khosla; L Joseph Melton; Shreyasee Amin
Journal:  J Bone Miner Res       Date:  2011-12       Impact factor: 6.741

3.  Eldecalcitol improves muscle strength and dynamic balance in postmenopausal women with osteoporosis: an open-label randomized controlled study.

Authors:  Kimio Saito; Naohisa Miyakoshi; Toshiki Matsunaga; Michio Hongo; Yuji Kasukawa; Yoichi Shimada
Journal:  J Bone Miner Metab       Date:  2015-07-25       Impact factor: 2.626

Review 4.  Vitamin D: a review on its effects on muscle strength, the risk of fall, and frailty.

Authors:  Matthieu Halfon; Olivier Phan; Daniel Teta
Journal:  Biomed Res Int       Date:  2015-04-27       Impact factor: 3.411

Review 5.  Harnessing Muscle-Liver Crosstalk to Treat Nonalcoholic Steatohepatitis.

Authors:  Manu V Chakravarthy; Mohammad S Siddiqui; Mikael F Forsgren; Arun J Sanyal
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-23       Impact factor: 5.555

6.  Vitamin D supplementation to prevent depression and poor physical function in older adults: Study protocol of the D-Vitaal study, a randomized placebo-controlled clinical trial.

Authors:  Elisa J de Koning; Natasja M van Schoor; Brenda W J H Penninx; Petra J M Elders; Annemieke C Heijboer; Jan H Smit; Pierre M Bet; Maurits W van Tulder; Martin den Heijer; Harm W J van Marwijk; Paul Lips
Journal:  BMC Geriatr       Date:  2015-11-19       Impact factor: 3.921

Review 7.  Vitamin D supplementation and its influence on muscle strength and mobility in community-dwelling older persons: a systematic review and meta-analysis.

Authors:  H Rosendahl-Riise; U Spielau; A H Ranhoff; O A Gudbrandsen; J Dierkes
Journal:  J Hum Nutr Diet       Date:  2016-07-27       Impact factor: 3.089

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.